# Regenerative Biologics Inc – FDA Inspection, Jan 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/e73b9cbe-56b9-4a0b-b460-7a05f7eab4a3
Source feed: FDA_Inspections

> FDA inspection 1194604 of Regenerative Biologics Inc, January 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194604
- Company Name: Regenerative Biologics Inc
- Inspection Date: 2023-01-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/164eb1d8-0996-45f8-bb98-9d8712860cd0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d